Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case information

Corcept Therapeutics Securities Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Corcept Therapeutics · Relacorilant · New Filing

Last updated

Case overview

Defendant company
Corcept Therapeutics
Product or service
Relacorilant
Case status
New Filing
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Lead Plaintiff Appointment

Participation information

Availability is based on each listed participation option and its deadline.

Lead Plaintiff Appointment

Shareholders who purchased Corcept Therapeutics shares during the class period from October 31, 2024 to December 30, 2025 may be eligible to seek appointment as lead plaintiff.

Contact DJS Law Group regarding a possible lead plaintiff appointment. Appointment as lead plaintiff is not required to participate in any recovery.

Type
Lead Plaintiff
Status
Deadline passed

Discuss Legal Rights

Investors who purchased or acquired Corcept common stock between October 31, 2024, and December 30, 2025 are invited to discuss their legal rights.

Contact Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato at (212) 355-4648.

Type
Law Firm Signup
Status
Unknown
Original press release

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.